These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6117440)

  • 1. Metabolism of arildone, an antiviral agent, in laboratory animals.
    Benziger DP; Fritz AK; Clemans SD; Edelson J
    Drug Metab Dispos; 1981; 9(5):424-7. PubMed ID: 6117440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of arildone, an antiviral agent, after various routes of administration.
    Benziger DP; Edelson J
    Antimicrob Agents Chemother; 1982 Sep; 22(3):475-81. PubMed ID: 6814356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disposition of acyclovir in different species.
    de Miranda P; Krasny HC; Page DA; Elion GB
    J Pharmacol Exp Ther; 1981 Nov; 219(2):309-15. PubMed ID: 7288622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
    Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
    Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs.
    Halpin RA; Geer LA; Zhang KE; Marks TM; Dean DC; Jones AN; Melillo D; Doss G; Vyas KP
    Drug Metab Dispos; 2000 Oct; 28(10):1244-54. PubMed ID: 10997947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of remoxipride in different species. Species differences in metabolism.
    Widman M; Nilsson LB; Bryske B; Lundström J
    Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Yoshida K; Itogawa A; Tagawa M; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1095-102. PubMed ID: 8267676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of the antipsychotic agent CI-1007 in rats, monkeys, dogs, and human cytochrome P450 2D6 extensive metabolizers. Species comparison and allometric scaling.
    Feng MR; Loo J; Wright J
    Drug Metab Dispos; 1998 Oct; 26(10):982-8. PubMed ID: 9763403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.
    Mamidi RN; Mannens G; Annaert P; Hendrickx J; Goris I; Bockx M; Janssen CG; Kao M; Kelley MF; Meuldermans W
    Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the metabolites of erythro-9-(2-hydroxy-3-nonyl)hypoxanthine from laboratory animals.
    Pfadenhauer EH; Bankert CS; Jensen J; Jones CE; Jenkins EE; McCloskey JA
    Drug Metab Dispos; 1984; 12(3):280-4. PubMed ID: 6145553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
    Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs.
    Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH
    Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and disposition of sulfinalol in laboratory animals.
    Benziger DP; Fritz A; Edelson J
    Drug Metab Dispos; 1981; 9(6):493-8. PubMed ID: 6120804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic disposition of the selective beta 1-adrenoceptor agonist prenalterol in mice, rats, dogs, and humans.
    Hoffmann KJ; Arfwidsson A; Borg KO
    Drug Metab Dispos; 1982; 10(2):173-9. PubMed ID: 6124405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic disposition of the cognition activator tacrine in rats, dogs, and humans. Species comparisons.
    Pool WF; Reily MD; Bjorge SM; Woolf TF
    Drug Metab Dispos; 1997 May; 25(5):590-7. PubMed ID: 9152598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans.
    Zhang D; He K; Raghavan N; Wang L; Mitroka J; Maxwell BD; Knabb RM; Frost C; Schuster A; Hao F; Gu Z; Humphreys WG; Grossman SJ
    Drug Metab Dispos; 2009 Aug; 37(8):1738-48. PubMed ID: 19420130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of the neuroleptic agent zetidoline in the rat and the dog.
    Assandri A; Perazzi A; Fontanella L; Ferrari P; Ripamonti A; Tarzia G; Tuan G; Martinelli E
    Drug Metab Dispos; 1984; 12(5):635-40. PubMed ID: 6149917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo metabolism of [14C]ruboxistaurin in dogs, mice, and rats following oral administration and the structure determination of its metabolites by liquid chromatography/mass spectrometry and NMR spectroscopy.
    Barbuch RJ; Campanale K; Hadden CE; Zmijewski M; Yi P; O'Bannon DD; Burkey JL; Kulanthaivel P
    Drug Metab Dispos; 2006 Feb; 34(2):213-24. PubMed ID: 16258078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
    Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
    Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.